新型基因療法成功治療遺傳性耳聾
New Gene Therapy Successfully Treats Hereditary Deafness
一項開創性的醫療突破已經為患有遺傳性耳聾的患者帶來了希望。
A groundbreaking medical advancement has arrived for those with hereditary deafness.
研究人員成功利用基因療法治療了一種稱為DFNB9的疾病，該疾病是由OTOF基因突變引起的。
Researchers have successfully utilized gene therapy to treat a condition called DFNB9, caused by mutations in the OTOF gene.
此基因對於產生耳鐵蛋白至關重要，該蛋白有助於將聲音訊號發送到大腦。
This gene is vital for producing the otoferlin protein, which helps send sound signals to the brain.
與依賴電子硬體的傳統人工耳蝸不同，這種治療解決了生物學上的根本原因。
Unlike traditional cochlear implants that rely on electronic hardware, this treatment addresses the biological root cause.
在臨床試驗中，科學家使用改良後的腺相關病毒作為傳遞載體，將功能性OTOF基因直接注射到內耳中。
In clinical trials, scientists used a modified adeno-associated virus as a delivery vehicle to inject a functional OTOF gene directly into the inner ear.
雖然目前仍處於試驗階段，但這一成功提供了一條有希望的途徑，無需外接設備即可恢復自然聽力，標誌著基因醫學的一個歷史性里程碑。
Though still in the trial phase, this success offers a promising path toward restoring natural hearing without the need for external devices, marking a historic milestone in genetic medicine.
